> Patients in respiratory failure develop blood clots in the lungs and tiny blockages in the lung's blood vessels. These tiny clots keep blood from reaching air spaces in the lungs, and that's where blood normally receives oxygen from the lungs.<p>This video gives what I thought was a good overview of how this comes about in this and similar diseases should they develop advanced respiratory failure symptoms<p><a href="https://youtu.be/PWzbArPgo-o" rel="nofollow">https://youtu.be/PWzbArPgo-o</a>
Repurposing existing drugs that have already passed safety assessments makes so much sense I was surprised the expert quoted even had to say it. Is this <i>not</i> standard procedure for research in normal times, and priority in a health emergency?